Domain Informations
Enspryng.com lookup results from whois.1api.net server:
- Domain created: 2013-09-09T10:36:08Z
- Domain updated: 2025-11-21T02:59:43Z
- Domain expires: 2026-09-09T10:36:08Z 0 Years, 222 Days left
- Website age: 12 Years, 142 Days
- Registrar Domain ID: 1826617041_DOMAIN_COM-VRSN
- Registrar Url: http://www.1api.net
- Registrar WHOIS Server: whois.1api.net
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +49.68949396850
- Name server:
- ALAN.NS.CLOUDFLARE.COM
- LARA.NS.CLOUDFLARE.COM
Network
- inetnum : 104.16.0.0 - 104.31.255.255
- name : CLOUDFLARENET
- handle : NET-104-16-0-0-1
- status : Direct Allocation
- created : 2010-07-09
- changed : 2024-11-25
- desc : All Cloudflare abuse reporting can be done via https://www.cloudflare.com/abuse,Geofeed: https://api.cloudflare.com/local-ip-ranges.csv
Owner
- organization : Cloudflare, Inc.
- handle : CLOUD14
- address : Array,San Francisco,CA,94107,US
Technical support
- handle : ADMIN2521-ARIN
- name : Admin
- phone : +1-650-319-8930
- email : [email protected]
Abuse
- handle : ABUSE2916-ARIN
- name : Abuse
- phone : +1-650-319-8930
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 104.18.30.32
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 104.18.30.32)
Spam Check (IP: 104.18.30.32)
Recent Searched Sites
› Iwaki-uniform.com (1 seconds ago) / US
› Creativesafetysupply.com (3 seconds ago) / US
› Iwate.dashimasu.com (1 seconds ago) / US
› Theschoolhouse.com.sg (1 seconds ago) / US
› Dynastyhouseseafood.com (1 seconds ago) / CA
› Kywags.org (2 seconds ago) / US
› Sma.uniguajira.edu.co (1 seconds ago) / US
› Theroyalvisions.com (2 seconds ago) / US
› Test-fibreoptique.fr (2 seconds ago) / FR
› Ibo.paineljp.com (5 seconds ago) / US
› Quadrecruitment.com (2 seconds ago) / DE
› Blog.luckytain.com (5 seconds ago) / US
› Ans-names.pitt.edu (0 seconds ago) / US
› Totm.inonu.edu.tr (2 seconds ago) / TR
› And-mg.jbplt.jp (3 seconds ago) / JP
› Lovepork.co.uk (2 seconds ago) / US
› Arthurs-hotels.ru (1 seconds ago) / RU
› Disntr.com (1 seconds ago) / US
› Enspryng.com (1 seconds ago) / US
› Everest-kom.ru (1 seconds ago) / RU
Websites Listing
We found Websites Listing below when search with enspryng.com on Search Engine
ENSPRYNG™ (satralizumab) | Neuromyelitis Optica …
Nausea. inflammation of the stomach lining (gastritis) joint pain (arthralgia) These are not all the possible side effects of ENSPRYNG. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA …
Enspryng.comContact a Representative | ENSPRYNG® (satralizumab)
This feature is intended for US healthcare professionals only. Please complete the form below if you would like a Genentech representative to contact you regarding your ENSPRYNG information request. You should receive a response within 2 business days. Your contact information will not be used for any other purpose than for the representative ...
Enspryng-hcp.comSign Up for Updates | ENSPRYNG™ (satralizumab)
Upper respiratory tract infection. nausea. inflammation of the stomach lining (gastritis) joint pain (arthralgia) These are not all the possible side effects of ENSPRYNG. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Genentech at 1-888-835-2555.
Enspryng.comClinical Trials & Side Effects | ENSPRYNG™ (satralizumab)
ENSPRYNG may cause serious side effects including: Infections. ENSPRYNG can increase your risk of serious infections some of which can be life-threatening. Talk to your healthcare provider if you are being treated for an infection or call them right away if you think you have signs of an infection, with or without a fever, such as: chills, feeling tired, muscle aches, cough that will not …
Enspryng.comLog in to Your Account - ENSPRYNG
Upper respiratory tract infection. nausea. inflammation of the stomach lining (gastritis) joint pain (arthralgia) These are not all the possible side effects of ENSPRYNG. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Genentech at 1-888-835-2555.
Enspryngcopay.comPRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION …
ENSPRYNG (satralizumab) injection is available as a sterile, preservative-free, clear, colourless to slightly yellow solution in a single-use pre-filled syringe (PFS) with needle safety device (NSD). Each ENSPRYNG carton contains one single-use 120 mg pre-filled syringe. Description ENSPRYNG is a recombinant humanized immunoglobulin G2 (IgG2) monoclonal antibody ® …
Rochecanada.comSitemap | ENSPRYNG™ (satralizumab)
ENSPRYNG may cause serious side effects including: Infections. ENSPRYNG can increase your risk of serious infections some of which can be life-threatening. Talk to your healthcare provider if you are being treated for an infection or call them right away if you think you have signs of an infection, with or without a fever, such as: chills, feeling tired, muscle aches, cough that will not …
Enspryng.comPRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION …
ENSPRYNG is given by injection under the skin (sub-cutaneously). Always use the entire contents of the syringe during injection. Usual dose: Each injection contains 120 mg of satralizumab. The first injection will be given under the supervision of your healthcare professional. The first three injections are given once every two weeks. These are called …
Rochecanada.comSubmit, Print or Download ENSPRYNG Forms & Documents
Download, view or print ENSPRYNG Access Solutions enrollment forms and other important documents. Submit enrollment forms online. Find sample letters of medical necessity and sample appeal letters. Skip To Main Content. US Patient Site. ENSPRYNG® (satralizumab-mwge) My Patient Solutions® Login Log in to My Patient Solutions® Call (877) 436-3683 Call (877) 436 …
Genentech-access.comRoche | Enspryng (satralizumab)
ENSPRYNG (satralizumab) is a humanised monoclonal antibody that targets the interleukin-6 (IL-6) receptor. IL-6 is a signalling protein, produced by immune cells in the body, believed to play a key role in the inflammation occurring in people with neuromyelitis optica spectrum disorder (NMOSD), leading to unpredictable and severe relapses. Enspryng is currently approved in …
Roche.comPlease follow these 3 steps to get started: Learn 1.
A representative from Genentech Access Solutions for ENSPRYNG or your doctor’s office will call you to tell you about your coverage, costs and support for your treatment. Please follow these 3 steps to get started: Read “Authorization to Use and Disclose Personal Information”on page 3. 1. Sign and date page 4. Please note you must sign the form to get support for your treatment. 2. …
Genentech-access.comFDA Approves Treatment for Rare Disease Affecting Optic Nerves, …
2020-08-17 · NMOSD is a rare autoimmune disease of the central nervous system that mainly affects the optic nerves and spinal cord. Enspryng is the third approved treatment for the disorder. “Until last year ...
Fda.govEnspryng Approved for NMOSD in European Union
2021-07-01 · The European Commission has approved Enspryng (satralizumab) for the treatment of people, 12 and older, with neuromyelitis optica spectrum disorder (NMOSD) who are positive for antibodies against the aquaporin-4 protein (AQP4-IgG). The approval covers Enspryng for use as a monotherapy (on its own) or in combination with other …
Neuromyelitisnews.comEnspryng (Satralizumab-mwge Injection for Subcutaneous ... - RxList
2021-05-18 · ENSPRYNG PFS is not made with natural rubber latex. Each ENSPRYNG carton contains one single-dose 120 mg/mL prefilled syringe (NDC 50242-007-01). Storage And Handling. Refrigerate at 2°C to 8°C (36°F to 46°F) in original carton to protect from light. Do not freeze. Do not shake. Prior to administration, ENSPRYNG, if unopened, can be removed from …
Rxlist.comEnspryng News | Enspryng
2020-08-15 · Roche gets U.S. approval for Enspryng, takes on Alexion's Soliris. Roche gets U.S. approval for Enspryng, takes on Alexion's Soliris. 8/15/2020 3:00:00 PM
Headtopics.comRoche's ENSPRYNG®️ (satralizumab) approved in Japan for …
2020-06-29 · ENSPRYNG is the first and only approved therapy targeting the interleukin-6 (IL-6) receptor given subcutaneously every four weeks Approval is supported by data demonstrating ENSPRYNG’s robust efficacy, which was well-tolerated with a consistent safety profile, in a broad NMOSD population as a monotherapy and as an add-on therapy
Marketscreener.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| clintonvilleauto.com | godaddy.com | -3 Years, -182 Days |
| raivaco.com | joker.com | -3 Years, -166 Days |
| mymission.com | wildwestdomains.com | -3 Years, -316 Days |
| lycocode.com | xinnet.com | -2 Years, -275 Days |
| cathaven.com | fastdomain.com | -3 Years, -107 Days |
| idlememe.com | isimtescil.net | -3 Years, -175 Days |
| gltv24.com | tucows.com | -3 Years, -96 Days |
| ourstage.com | godaddy.com | -2 Years, -363 Days |
| roadie.io | namecheap.com | -2 Years, -359 Days |
| send99.com | internet.bs | -3 Years, -305 Days |